Benjamin Hohl
Chief Financial Officer at Enliven Therapeutics, Inc. (ELVN) since February 2023
Benjamin Hohl has filed 51 insider reports with the SEC since February 2023, as chief Financial Officer at Enliven Therapeutics, Inc. (ELVN). In the last 12 months Benjamin Hohl sold $1.53M of stock on the open market. In the latest filing, on September 21, 2026, Benjamin Hohl sold 6,018 shares of Enliven Therapeutics, Inc. (ELVN) for $303K at an average of $50.35.
- Filings
- 51
- Companies
- 1
- Bought on market
- None
- Sold on market
- $4.51M
Companies where Benjamin Hohl is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Financial Officersince February 2023 | 38,000 | $4.51M | $44.89 | Sep 21, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 17, 2026-$303KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 3,982 shares at a strike of $14.85 and sold $303,003 worth of shares (6,018 units at $50.35) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 38,000 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 17, 2026-$353KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin sold $352,551 worth of shares (6,018 units at $58.58) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 40,036 unitsForm 4Open-market sale10b5-1 plan
- Jul 17, 2026-$317KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin sold $316,780 worth of shares (6,018 units at $52.64) as part of a pre-agreed trading plan and exercised 1,072 shares at a strike of $2.48, decreasing direct ownership by 10% to 46,054 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 17, 2026-$264KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 6,018 shares at a strike of $2.48 and sold $263,577 worth of shares (6,018 units at $43.80) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 6, 2026-$296KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin sold $295,839 worth of shares (10,000 units at $29.58), decreasing direct ownership by 16% to 51,000 unitsForm 4Open-market sale
- Feb 12, 2026ELVNCHIEF FINANCIAL OFFICER Hohl Benjamin was granted 25,000 shares, increasing direct ownership by 69% to 61,000 unitsForm 4Grant or award
- Dec 22, 2025ELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 13,000 shares at a strike of $2.48, increasing direct ownership by 57% to 36,000 unitsForm 4Exercise or conversion of a derivative
- Sep 29, 2025-$66.3KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 3,250 shares at a strike of $2.48 and sold $66,291 worth of shares (3,250 units at $20.40)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 29, 2025~$90KELVNBenjamin Hohl plans to sell 4,500 shares (~$90K)Form 144Planned sale10b5-1 plan
- Aug 27, 2025-$67KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 3,250 shares at a strike of $2.48 and sold $67,039 worth of shares (3,250 units at $20.63)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 27, 2025~$107KELVNBenjamin Hohl plans to sell 5,250 shares (~$107K)Form 144Planned sale10b5-1 plan
- Jul 28, 2025-$66.5KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 3,250 shares at a strike of $2.48 and sold $66,504 worth of shares (3,250 units at $20.46)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jul 10, 2025-$22.7KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 1,000 shares at a strike of $2.48 and sold $22,655 worth of shares (1,000 units at $22.66)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 27, 2025-$68KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 3,250 shares at a strike of $2.48 and sold $67,956 worth of shares (3,250 units at $20.91)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 13, 2025-$67.7KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 3,000 shares at a strike of $2.48 and sold $67,655 worth of shares (3,000 units at $22.55)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 27, 2025-$52.6KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 3,250 shares at a strike of $2.48 and sold $52,593 worth of shares (3,250 units at $16.18)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Apr 28, 2025-$60.7KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 3,250 shares at a strike of $2.48 and sold $60,738 worth of shares (3,250 units at $18.69)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 27, 2025-$69.3KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 3,250 shares at a strike of $2.48 and sold $69,321 worth of shares (3,250 units at $21.33)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 24, 2025-$22.5KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 1,000 shares at a strike of $2.48 and sold $22,504 worth of shares (1,000 units at $22.50)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 4, 2025ELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 10,000 shares at a strike of $2.48, increasing direct ownership by 77% to 23,000 unitsForm 4Exercise or conversion of a derivative
- Feb 27, 2025-$66.3KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 3,250 shares at a strike of $2.48 and sold $66,327 worth of shares (3,250 units at $20.41)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 6, 2025ELVNSEC Form 4 filed by CHIEF FINANCIAL OFFICER Hohl BenjaminForm 4Grant or award
- Feb 5, 2025-$22.5KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 1,000 shares at a strike of $2.48 and sold $22,524 worth of shares (1,000 units at $22.52)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jan 27, 2025-$70.2KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 3,250 shares at a strike of $2.48 and sold $70,178 worth of shares (3,250 units at $21.59)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jan 3, 2025-$25KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 14,000 shares at a strike of $2.48 and sold $25,039 worth of shares (1,000 units at $25.04)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 30, 2024-$94.5KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 4,250 shares at a strike of $2.48 and sold $94,474 worth of shares (4,250 units at $22.23)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Nov 27, 2024-$131KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 5,250 shares at a strike of $2.48 and sold $130,688 worth of shares (5,250 units at $24.89)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Oct 28, 2024-$178KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 6,250 shares at a strike of $2.48 and sold $178,485 worth of shares (6,250 units at $28.56)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Oct 18, 2024-$24.4KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 814 shares at a strike of $2.48 and sold $24,422 worth of shares (814 units at $30.00)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Oct 7, 2024-$316KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 11,488 shares at a strike of $2.48 and sold $316,014 worth of shares (11,488 units at $27.51)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Oct 1, 2024-$14.3KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 521 shares at a strike of $2.48 and sold $14,347 worth of shares (521 units at $27.54)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 30, 2024-$154KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin sold $153,829 worth of shares (6,250 units at $24.61) and exercised 6,250 shares at a strike of $2.48Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 27, 2024-$95.8KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 4,250 shares at a strike of $2.48 and sold $95,782 worth of shares (4,250 units at $22.54)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jul 31, 2024-$27.3KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 991 shares at a strike of $2.48 and sold $27,281 worth of shares (991 units at $27.53)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jul 29, 2024-$140KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 5,250 shares at a strike of $2.48 and sold $140,052 worth of shares (5,250 units at $26.68)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jul 31, 2024~$287KELVNBenjamin Hohl plans to sell 11,000 shares (~$287K)Form 144Planned sale10b5-1 plan
- Jul 12, 2024-$75.2KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 3,000 shares at a strike of $2.48 and sold $75,195 worth of shares (3,000 units at $25.07)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 27, 2024-$95.9KELVNCHIEF FINANCIAL OFFICER Hohl Benjamin exercised 4,250 shares at a strike of $2.48 and sold $95,922 worth of shares (4,250 units at $22.57)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 28, 2024-$98.5KELVNHohl Benjamin exercised 4,250 shares at a strike of $2.48 and sold $98,530 worth of shares (4,250 units at $23.18)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 3, 2024-$22.5KELVNHohl Benjamin exercised 1,000 shares at a strike of $2.48 and sold $22,500 worth of shares (1,000 units at $22.50)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Apr 29, 2024-$55.2KELVNHohl Benjamin exercised 3,250 shares at a strike of $2.48 and sold $55,165 worth of shares (3,250 units at $16.97)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Apr 11, 2024-$346KELVNHohl Benjamin exercised 14,000 shares at a strike of $2.48 and sold $346,149 worth of shares (14,000 units at $24.72)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 27, 2024-$59.3KELVNHohl Benjamin exercised 3,250 shares at a strike of $2.48 and sold $59,302 worth of shares (3,250 units at $18.25)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 27, 2024-$55.2KELVNHohl Benjamin exercised 3,250 shares at a strike of $2.48 and sold $55,163 worth of shares (3,250 units at $16.97)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 13, 2024ELVNSEC Form 4 filed by Hohl BenjaminForm 4Grant or award
- Jan 29, 2024-$51.4KELVNHohl Benjamin exercised 3,250 shares at a strike of $2.48 and sold $51,388 worth of shares (3,250 units at $15.81)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jan 2, 2024-$178KELVNHohl Benjamin exercised 11,870 shares at a strike of $2.48 and sold $178,327 worth of shares (11,870 units at $15.02)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 26, 2023-$17KELVNHohl Benjamin exercised 1,130 shares at a strike of $2.48 and sold $17,025 worth of shares (1,130 units at $15.07)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Apr 4, 2023ELVNSEC Form 4 filed by Hohl BenjaminForm 4Grant or award
- Feb 23, 2023ELVNSEC Form 4 filed by Hohl BenjaminForm 4Grant or award
- Feb 23, 2023ELVNBenjamin Hohl became an insiderForm 3New insider
Compare Benjamin Hohl with
- Benjamin Hohl vs Lori Anne Kunkel1 shared
- Benjamin Hohl vs J. Scott Garland1 shared
- Benjamin Hohl vs Helen Louise Collins1 shared
- Benjamin Hohl vs Richard A. Heyman1 shared
- Benjamin Hohl vs Mika K Derynck1 shared
- Benjamin Hohl vs Rishi Gupta1 shared
Other insiders at the same companies
- Lori Anne KunkelELVN
- J. Scott GarlandELVN
- Helen Louise CollinsELVN
- Richard A. HeymanELVN
- Mika K DerynckELVN
- Orbimed Advisors LLCELVN
- The Biotech Growth Trust PLCELVN
- Rishi GuptaELVN
- Jake BauerELVN
- Rahul D. BallalELVN
- Anish PatelELVN
- Joseph P LyssikatosELVN
- Richard A. FairELVN
- Samuel KintzELVN
- Andrew John PhillipsELVN
Questions about Benjamin Hohl
- What is Benjamin Hohl's role at Enliven Therapeutics, Inc.?
- Benjamin Hohl reports to the SEC as chief Financial Officer at Enliven Therapeutics, Inc. (ELVN), according to the latest filing on September 21, 2026.
- How many shares does Benjamin Hohl own?
- After the latest filing that states it, Benjamin Hohl directly owned 38,000 shares of Enliven Therapeutics, Inc. (ELVN). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Benjamin Hohl bought or sold stock recently?
- The most recent open-market sale was on September 17, 2026: sold 6,018 shares of Enliven Therapeutics, Inc. (ELVN) for $303K at an average of $50.35.
- How do I get alerts when Benjamin Hohl files?
- Follow Benjamin Hohl on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Benjamin Hohl filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Benjamin Hohl (SEC CIK 0001882764). Totals count each trade once, skipping amendments whose original is on file, from Feb 28, 2023 on. View on SEC EDGAR